Although the role of vitamin B12 in relation to diabetes mellitus is not fully understood, there are evidences to substantiate that this micronutrient plays an im portant role directly or indirectly in carbohydrate metabolism (1) . It has been shown to relieve hyperglycemia and glycosuria (2) under various experimental con ditions.
A decrease in the activities of glycolytic enzymes and some other SH enzymes in vitamin B12 deficiency was also reported by Biswas and Johnson (3) .
The vitamin B12 levels of serum and urine in diabetic patients with or without retinopathy, has been a subject of conjecture as controversial reports have been obtained by different workers on the subject (4, 5) . According to some, diabetics with retinopathy excrete significantly more of the vitamin than non-diabetics, while diabetics without retinopathy excrete considerably less amounts of the vitamin than the nondiabetics (4). On the other hand, Bookman et al. (5) found a lack of cor relation with vitamin Bi2 excretion in diabetics (with or without retinopathy) and normal subjects.
Serum levels of vitamin B12 in diabetics with retinopathy was found to be much higher than those without retinopathy (6) . However, others failed to find significant difference in serum vitamin B12 levels between diabetics and normal persons (7). However, a decreased blood vitamin B12 in diabetes mellitus was evidenced by some other workers (8) . In view of the above observations it was thought worthwhile to investigate into the true picture of vitamin B12 status in diabetes.
In the earlier reports it has been shown that the vitamin B12 levels of the serum and liver decrease with higher ketone bodies in the animal system (9, 10) . In the present investigation, therefore, vitamin B12 levels of serum and liver were estimated in alloxan diabetic animals under different levels of ketone bodies.
METHODS AND MATERIALS
Fifty male albino rats weighing 100-150g were fed on laboratory stock diet. They were divided equally into five different groups. Group I animals were normal controls. Animals from rest of the groups were injected subcutenously with alloxan (10mg/100g body weight). Group III animals were again injected on the subsequent day with alloxan (8mg/100g body weight).
Animals from group IV and V were simulteneously injected with acetoacetate 10 and 15mg/100g body weight, respec tively, daily for 30days.
Blood sugar and ketone bodies were assayed every week by the standard procedures (11, 12) . At the end of 30days animals from all the groups were sacrificed and blood collected. Tissues such as liver and kideny were removed, chilled and prepared for vitamin B12 assay. Blood and tissue vitamin B12 levels were estimated microbiologically by the standard method (13) . Hepatic con stituents such as liver sulfhydryl, RNA, DNA, and protein were estimated by the usual procedures (14) (15) (16) (17) .
RESULTS
From Figure 1 it becomes clear that acetoacetate injection along with alloxan made the animal more susceptible to diabetes as indicated by the high blood sugar levels. It is interesting to note that although blood sugar of animals from group II comes down considerably at the end of 30days, animals from the rest of the diabetic groups maintained a high level of blood sugar till their sacrifice. This is in confirmation with the earlier works of Nath and his coworkers who had shown increased susceptibility to diabetes by acetoacetate in animal (18) . Animals from group III, getting alloxan for two subsequent days, maintained a higher levels of ketone bodies throughout the experiment (see Fig. 2 showed higher levels of blood ketone bodies maintained throughout the experiment when compared to those of group II (Diabetic control). It is evident from Table I that although alloxan diabetic animals (group II) getting a single dose of alloxan did not have any significant alteration in the vitamin B12 levels of either blood or tissue of those diabetic animals, which were having a high level of ketone bodies maintained for a prolonged period, showed a significant decrease in blood and tissue vitamin B12 levels. The maximum deleterious effect was found in animals from group V. This was followed by animals from group IV and III. The above findings suggest that diabetic animals would cause an increased requirement of vitamin B12 only when the animals maintained high levels of ketone bodies during the diabetic state per se. The picture of hepatic constituents of animals from various groups are described in Table 2 . Hepatic RNA, protein and total sulfhydryl were decreased considerably in animals of group III, IV and V. The animals affected most were those of group V. Hepatic DNA, however, did not show appreciable alteration in any of the groups.
DISCUSSIONS
Although contradictory evidences on vitamin B12 status were reported by the earlier workers (4, 5) in diabetes, little ffforts were made by them to supply with a possible explanation for the above differences on the subject. Our results clearly show that although in diabetic animals the vitaminBl2 status did not change on one injection of alloxan, the maintenance of ketone bodies in the diabetic state caused much decrease in blood and tissue vitamin B12 at the end of 30days. The decrease was also found to be in proportion to the blood ketone bodies in the animals. The low serum vitamin B12 levels in diabetics found by earlier workers (8) were probably only in cases, where a state of ketosis prevailed for a considerable amount of time. In this context, it is worth mentioning that our preliminary findings on vitamin B12 levels in diabetic patients showed a considerable decrease in serum vitamin B12 levels only when the patient had severe ketosis for a prolonged period.
From the present investigation it becomes evident that vitamin B12 has some close relationship with ketone bodies.
